CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $178K of Crinetics Pharmaceuticals, Inc.
Sold$178,475
$21.43Price
8,328Shares
−6%Stake
What CRNX did after the filing
- The stock from Fri, Apr 1 close, $23.58
- −14.0%
- S&P 500, same days
- −11.7%
Measured over 30 trading days, to the May 16 close.
Traded Thu, Mar 31. Filed Fri, Apr 1, 1:39 PM ET, during the session. Returns use the Apr 1 close and the May 16 close. Not investment advice.